The Complete Stimulant Titration Timeline: Week by Week

Disclaimer: This article is a general educational guide to how stimulant titration usually proceeds. Your prescriber's plan for you may differ based on your medical history, other medications, and individual response. Never adjust your dose or timing without explicit instruction from your prescriber.

If you've just been prescribed a stimulant medication for ADHD, your prescriber likely handed you a plan that starts low, goes slow, and involves regular check-ins. That process has a name: titration. In the words of the UK's NICE guideline, the dose is adjusted against symptoms and side effects until you get reduced symptoms and real improvements at work, at home and in relationships, with side effects you can tolerate [1].

This guide walks through what a typical stimulant titration looks like week by week. The exact numbers differ by drug, but the structure is similar across them.

What is stimulant titration?

Titration is the controlled process of your prescriber starting a new medication carefully and adjusting it in steps while you both watch the response. NICE NG87 says that during titration, symptoms, impairment and side effects should be recorded at baseline and at each dose change on standard scales, with progress reviewed regularly, for example by weekly phone contact with a specialist [1]. The Canadian CADDRA guideline also recommends regular contact during titration and describes the general rule as "start low and go slow" [2]. Your prescriber decides every dose and every change.

Stimulants act within hours. In the Vyvanse label's adult study, for example, the benefit over placebo was already measurable 2 hours after the dose [3]. That makes the feedback loop fast, but it also means side effects and benefits show up quickly and need to be evaluated together.

Week 0 — Baseline and pre-titration evaluation

Before you take your first dose, NICE says your prescriber should do a baseline assessment [1]. This usually involves:

A review of your mental health, other conditions and current medication
Recording your pulse, blood pressure, height and weight, plus a heart (cardiovascular) assessment
A symptom measurement on a standard rating scale (for adults this is often a questionnaire such as the ASRS v1.1)
Choosing a starting dose and formulation

NICE also asks for slower titration and more frequent monitoring if you have conditions such as anxiety, autism, tics, heart disease or epilepsy [1].

What you should do this week:

Fill any questionnaires your prescriber sends you, because the baseline score is what "better" is measured against
Note your current sleep pattern and wake-up time (stimulant timing hinges on this)
Get clear on when to take your first dose and whether to take it with food

Week 1 — Starting dose

Your first week is about safety and tolerability, not therapeutic effect. Starting doses are deliberately low, and your prescriber chooses yours.

What to expect:

On Day 1, you may notice a subtle shift: a bit more focus, slightly less mental noise, or just a sense of being "quieter inside." How long it lasts depends heavily on the formulation. Some people feel nothing at this dose, and that's normal, because you're not expected to be at a therapeutic level yet.

Side effects in week 1 are common:

Reduced appetite (one of the most common side effects across stimulant labels) [3][4][5]
Slightly elevated heart rate or feeling "wired"
Trouble falling asleep
Dry mouth, mild headache, or a jittery feeling during the peak

What to log this week:

Time you took the dose and the amount
Energy and focus every 2–3 hours after dosing (you'll notice the curve form)
Any side effects and when they occur
Sleep onset and quality that night

Week 2 — First adjustment

By the second week, you and your prescriber may have enough data for a first decision about the dose. The Vyvanse and Concerta labels both describe dose changes at roughly weekly intervals, and NICE recommends checking heart rate and blood pressure before and after each dose change [1][3][4].

What to look for this week:

Do you notice a longer window of effect? (Does the effect seem to cover most of your day yet?)
Has the side-effect intensity stayed the same, or intensified after any change your prescriber made?
Are you still falling asleep within a reasonable window?

The goal at this stage is not perfection. It's about establishing that the medication is effective and tolerable enough to continue adjusting. If side effects are too intense, particularly appetite suppression, anxiety, or cardiovascular symptoms, your prescriber may choose to stay at the current dose longer or try a different formulation entirely.

Weeks 3–4 — Fine-tuning

By weeks 3–4, many people have a clearer sense of whether the medication is helping, and the question shifts from "is this working?" to "could it work better, and is that a conversation to have with your prescriber?"

The side-effect benefit trade-off becomes clear around now:

If you get most of the relief with mild appetite suppression but notice significant insomnia, write that down and raise it with your prescriber.
If a change in your plan feels almost identical to before, log that too. It helps your prescriber see whether the change made a difference.
If side effects are interfering with function (you can't eat lunch, you're not sleeping, you're anxious), say so plainly. CADDRA notes that side effects sometimes limit how far a dose can go [2].

Rebound pattern: By weeks 3–4, you should be able to feel your medication's onset, peak, and wear-off more clearly. CADDRA describes "rebound" as symptoms coming back, or feeling worse than before treatment, as a dose wears off, and says it should prompt a look at coverage for that part of the day [2]. Logging the time it starts, and what it feels like (fatigue, irritability, hunger, a return of ADHD symptoms), gives your prescriber something concrete to work with.

Options the guidelines mention for this window include:

Moving from an immediate-release to a longer-acting formulation [2]
A smaller short-acting dose that overlaps the tail end of a long-acting one [2]
For methylphenidate, a modified-release dose in the morning plus an immediate-release dose at another time of day [1]

Per-medication timeline highlights

The numbers below come from each drug's US prescribing information. Labels report blood levels and dosing schedules; they rarely give a single "duration" figure, so where one is missing we say so.

Vyvanse (lisdexamfetamine)

Vyvanse is a prodrug: it is inactive until it is converted, mainly in the blood, into dextroamphetamine [3].

Onset: In the label's studies, the benefit was measurable at 2 hours; in children it was not yet significant at 1 hour
Peak blood level: about 3.8 hours in fasted adults (about 4.7 hours after a high-fat meal)
Duration: In an adult workplace study, it beat placebo at every time point from 2 to 14 hours after the dose; in children, from 2 to 12 hours
Titration: The label describes changes at roughly weekly intervals; your prescriber sets the starting dose and any changes.
What to watch: Because it lasts all day, the label says to take it in the morning and avoid afternoon doses because of the potential for insomnia.

Adderall XR (mixed amphetamine salts extended-release)

Adderall XR capsules contain two kinds of beads, immediate-release and delayed-release, which stretch out the release of amphetamine compared with the immediate-release tablet [5].

Onset: Not stated in the label
Peak blood level: about 7 hours
Duration: Not stated in the label
Titration: Your prescriber sets the starting dose and any weekly changes.
What to watch: The label says to take it on waking and to avoid afternoon doses because of the potential for insomnia.

Adderall IR (immediate-release)

Immediate-release amphetamine is usually taken more than once a day.

Onset: Not stated in the label
Peak blood level: about 3 hours
Dosing pattern: First dose on waking, then one or two more doses at intervals of 4 to 6 hours [6]
Titration: Your prescriber sets the starting dose and any weekly changes.
What to watch: The label says late-evening doses should be avoided because of insomnia. Log how each dose fades, because the gap between doses is where many people notice a dip.

Methylphenidate IR / Ritalin

The shortest-acting of these options, which gives flexible control but more doses to remember.

Onset: Not stated in the label
Peak blood level: about 2 hours after a 10 mg tablet
Dosing pattern: Two or three divided doses a day, preferably 30 to 45 minutes before meals [7]
Titration: Your prescriber sets the starting dose and any weekly changes.
What to watch: More doses mean more reminders and more points in the day where an effect wears off. The label says people who can't sleep when they take it late in the day should take the last dose before 6 p.m.

Concerta (methylphenidate extended-release)

Concerta uses an osmotic-release tablet to spread one morning dose across the day [4].

Onset: Blood levels reach a first high point at about 1 hour
Peak blood level: between 6 and 10 hours
Duration: In the children's studies, the benefit was maintained through 12 hours; no adult figure is given
Titration: The label describes 18 mg steps at weekly intervals; your prescriber sets the starting dose and any changes.
What to watch: The label says to swallow it whole and not to split, crush or chew it.

When to call your prescriber

During titration, contact your prescriber (or urgent care) for:

Chest pain, heart palpitations, or fainting: seek urgent medical care now (call emergency services if severe)
Weight loss that worries you or meals you keep missing
Suicidal thoughts: for crisis support, call 988 (US) or your local crisis line
Hallucinations or paranoia (rare, but a known stimulant adverse effect)
New or worsening anxiety that feels unmanageable
Allergic reaction: rash, hives, swelling

For less urgent but still meaningful signals, such as appetite so low you've missed multiple meals, consistent insomnia, or symptoms that feel worse than baseline, contact your prescriber before the next scheduled check-in rather than pushing through. There is no virtue in suffering through a titration schedule that isn't working.

How tracking helps

The single most useful thing you can do during titration is log what's happening as it happens. NICE encourages people taking ADHD medication to monitor and record their side effects, for example with a side-effect checklist [1]. Asking systematically matters: in children's medication trials, a body-system review of side effects found about three times as many adverse events as general questioning [8]. Memory, by comparison, tends to squash weeks of experience into however you feel on the day of the appointment.

A tracker like Titrate handles this automatically: one-tap dose logs, timed check-ins that align to your medication's pharmacokinetics, and a structured side-effect checklist. At your appointment, you hand over a report showing dose-response curves, side-effect incidence per dose level, and functional change over the entire titration window, instead of relying on what you remember.

→ Start tracking your titration ← → What your prescriber sees when you share your report ←

Key takeaways

Stimulant titration means adjusting the dose in steps, with symptoms and side effects recorded at each change and regular reviews along the way
Side effects at the starting dose are normal; the goal is finding the level where benefit clearly outweighs burden
Each medication has its own profile: Vyvanse's benefit lasted up to 14 hours in an adult study, while IR methylphenidate is taken two or three times a day
Note when rebound symptoms show up and bring that pattern to your prescriber
Logging in real time is far more accurate than retrospective recall, and it's the single best thing you can do for your titration appointments

FAQ

Q: What if I feel nothing at the starting dose? That's normal. The first week is mostly a tolerability check, and benefit often shows up in the following weeks. Report "no effect" at your check-in and let your prescriber decide what happens next.

Q: Can I skip a dose or take extra? Don't change your doses on your own. Ask your prescriber or pharmacist ahead of time what to do if you miss a dose, because the answer depends on the medication and the time of day. If you take too much, call your prescriber or Poison Help (1-800-222-1222 in the US), and seek emergency care for chest pain or fainting.

Q: How long does it take to know if a stimulant is right for me? It varies. Some people know within days that the side effects are out of proportion to the benefit. For adults, NICE describes a 6-week trial at an adequate dose before a switch to another stimulant is considered, and some people need more than one medication trial to find the right fit.

Q: Can I drink coffee during titration? Caffeine is a stimulant too, so it's worth telling your prescriber how much you drink. Logging your caffeine alongside your doses also helps, because big day-to-day swings can blur your titration data.

Q: What formulation gives the flattest effect? Long-acting formulations spread one dose across the day, and CADDRA notes they may reduce rebound compared with immediate-release stimulants. Vyvanse and Concerta are both long-acting; immediate-release tablets are taken several times a day and wear off between doses. Which one suits you is a comfort and coverage question for you and your prescriber.

Q: What if I miss my check-in week? Contact the clinic to rebook as soon as you can. Any change to your dose is your prescriber's call, so keep logging in the meantime and bring that data to the next appointment.

References

NICE Guideline NG87 — Attention deficit hyperactivity disorder: diagnosis and management (2018, last updated 2019). Recommendations 1.7.4, 1.7.12, 1.7.22, 1.7.26–1.7.28, 1.8.2, 1.8.3 and 1.8.9. Available at: https://www.nice.org.uk/guidance/ng87/chapter/Recommendations
Canadian ADHD Resource Alliance (CADDRA) — Canadian ADHD Practice Guidelines, 4.1 edition (2020). Available at: https://adhdlearn.caddra.ca/wp-content/uploads/2022/08/Canadian-ADHD-Practice-Guidelines-4.1-January-6-2021.pdf
Vyvanse (lisdexamfetamine dimesylate) — FDA Prescribing Information. Available at: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=704e4378-ca83-445c-8b45-3cfa51c1ecad
Concerta (methylphenidate HCl) Extended-Release Tablets — FDA Prescribing Information. Available at: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1a88218c-5b18-4220-8f56-526de1a276cd
Adderall XR (mixed amphetamine salts) — FDA Prescribing Information. Available at: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=aff45863-ffe1-4d4f-8acf-c7081512a6c0
Adderall (mixed amphetamine salts) tablets — FDA Prescribing Information. Available at: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f22635fe-821d-4cde-aa12-419f8b53db81
Ritalin (methylphenidate hydrochloride) tablets — FDA Prescribing Information. Available at: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d6fb2750-cdab-4749-ba0d-7534840a5892
Coates M, Spanos M, Parmar P, Chandrasekhar T, Sikich L. A review of methods for monitoring adverse events in pediatric psychopharmacology clinical trials. Drug Saf. 2018. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC5938315/

This article is for educational purposes only. It does not constitute medical advice. Always consult your licensed healthcare provider about medication decisions.